Asahi Kasei Zoll Medical, the Japanese subsidiary of Zoll Medical, has obtained Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its X Series monitor/defibrillator, designed primarily for emergency medical ...
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection ...
Tags: Gilead Sciences, Chronic Hepatitis
Medtronic, a medical technology company, has announced CE Mark approval in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its Symplicity Spyral catheter and Symplicity G3 radio frequency (RF) generator. ...
Tags: Medtronic, medical technology
OncoMed Pharmaceuticals and Celgene have entered into an agreement to jointly develop and commercialize about six anti-cancer stem cell (CSC) product candidates from OncoMed's biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). ...
Tags: clinical studies, Medicine, OncoMed
NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
InnaVirVax, a biopharmaceutical company, has commenced a Phase II clinical trial evaluating the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy (ART) in the course of HIV-1 infection. The ...
Baxter International has filed an amended biologics license application (BLA) to the US Food and Drug Administration (FDA) to re-start the review process for approval of HyQvia facilitated subcutaneous infusion to treat adult patients with ...
CDRD Ventures, the commercialization vehicle of The Centre for Drug Research and Development (CDRD), has announced the launch of a new spin-off company, Sitka Biopharma is a biotechnology company developing a new bladder cancer treatment. ...
A male contraceptive could be on the horizon after a discovery of a novel way to block the transport of sperm during ejaculation, Australian researchers say. Lead researchers, Dr. Sab Ventura and Dr. Carl White of the Monash Institute of ...
Tags: 'male Pill', male contraceptive
When used properly, the power of essential oils lies in their ability to deliver the beneficial healing properties of certain plants in a direct and highly concentrated form. Recognized long ago for their therapeutic properties, ancient ...
Tags: Essential Oils, Light Industry, Daily Use
VBL Therapeutics has secured fast track status from the US Food and Drug Administration (FDA) for its lead oncology drug VB-111, for prolongation of survival in patients with Recurrent Glioblastoma Multiforme (rGBM). VB-111 was already ...
Theraclone Sciences has received notification from the Biomedical Advanced Research and Development Authority (BARDA) informing the company that their proposal, 'Broad-spectrum anti-influenza A M2e fully human monoclonal antibody TCN-032: ...
QRxPharma, an Australian-based commercial-stage specialty pharmaceutical company, has resubmitted its MOXDUO new drug application (NDA). At a meeting in early October 2013, the US Food and Drug Administration (FDA) provided QRxPharma with ...
Tags: QRxPharma, Drug Application
US-based Biozone Pharmaceuticals has announced that it has agreed to terms and signed a letter of intent (LOI) to merge with Cocrystal Discovery, a privately-held biotechnology company developing antiviral therapeutics for human diseases. ...
Editas Medicine, a transformative genome editing company, today announced it has secured a $43m Series A financing led by Flagship Ventures, Polaris Partners and Third Rock Ventures with participation from Partners Innovation Fund. ...
Tags: Editas Medicine, genome editing